Public Sector Pension Investment Board Neurocrine Biosciences Inc Transaction History

Public Sector Pension Investment Board

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$83.82 - $101.5 $3.77 Million - $4.57 Million	-45,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$72.24 - $91.27 $2.75 Million - $3.47 Million	-38,000 Reduced 45.78%	45,000 $3.8 Million
Q1 2019 May 14, 2019	BUY	$69.31 - $91.53 $5.75 Million - $7.6 Million	83,000 New	83,000 $7.31 Million

638

93.8M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.